000			02132 a2200577 4500
005			20250516131750.0
264		0	_c20140213
008			201402s 0 0 eng d
022			_a1938-0682
024	7		_a10.1016/j.clgc.2012.12.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlesius, Aurore
245	0	0	_aAre tyrosine kinase inhibitors still active in patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus? Experience of 36 patients treated in France in the RECORD-1 Trial. _h[electronic resource]
260			_bClinical genitourinary cancer _cJun 2013
300			_a128-33 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzimidazoles _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aFrance
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aQuinolones _xtherapeutic use
650	0	4	_aSalvage Therapy
650	0	4	_aSirolimus _xanalogs & derivatives
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTreatment Failure
650	0	4	_aTreatment Outcome
700	1		_aBeuselinck, Benoit
700	1		_aChevreau, Christine
700	1		_aRavaud, Alain
700	1		_aRolland, Frédéric
700	1		_aOudard, Stéphane
700	1		_aEscudier, Bernard
773	0		_tClinical genitourinary cancer _gvol. 11 _gno. 2 _gp. 128-33
856	4	0	_uhttps://doi.org/10.1016/j.clgc.2012.12.001 _zAvailable from publisher's website
999			_c22431915 _d22431915